Most Recent
Kicking off its appeal of a finding that it couldn't walk away from a $672 million merger agreement with Mayne Pharma, US drug company Cosette has told a court that Mayne was not upfront about its financial position prior to the deal.
Passengers in a lawsuit against Qatar Airways over a 2020 strip search at Doha International Airport have reached a settlement with the airline and airport operator MATAR.
Insurance Australia Limited has settled $4 billion action brought by Germany's Greensill Bank and its administrator ahead of a six-month trial against the insurer and others over the failure of the trade financier.
Saint Gobain-owned CSR has been ordered to produce monthly performance reports for four of its business units and its building products division, in a competition case by insulation distributor Consolidated Energy.
Star's former group general counsel has told a judge she should not have to pay a $1.1 million fine for breaching her directors duties because she has suffered “extra-curial detriment” that includes unemployment.
Construction PRO
Dexus has lost its case over the validity of a default notice issued by Melbourne Aiport's operator, with a judge saying the real estate asset manager breached the company's confidentiality and "irrevocably undermined" its relationship with fellow shareholders.
Construction PRO
Heads may roll after a court on Friday rejected the evidence of key Dexus employees at trial over a breach of APAC's shareholder deed, in a ruling that revealed some insiders suspected the "embarassing blunder" would come back to bite.
Construction PRO
A judge has ordered that the names of the funders who backed unsuccessful proceedings over the failed Pentridge Village development in Melbourne be handed over.
Construction PRO
Saint Gobain-owned CSR has been ordered to hand over monthly performance reports for four business units and its building products division, in a misuse of market power case by insulation distributor Consolidated Energy.
US drug maker Cosette is appealing a judge’s decision not to disqualify himself from Mayne Pharma's lawsuit seeking damages over the termination of their $672 million if he is appointed to case manage the dispute.